HCRT and narcolepsy-cataplexy syndrome: In the present study, we found no evidence of humoral immunity against human OX1 or OX2 orexin receptors or the prepro-orexin molecule in a relatively large collection of serum specimens obtained from narcolepsy type 1 patients whose disease onset was associated with the use of Pandemrix vaccine.